Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Pescott
Mo2 - Modelling Overall Survival in Immunotherapy Using Parametric Techniques: Avelumab in Previously Treated Metastatic Merkel Cell Carcinoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Updated Efficacy of Avelumab in Patients With Previously Treated Metastatic Merkel Cell Carcinoma After ≥1 Year of Follow-Up: JAVELIN Merkel 200, a Phase 2 Clinical Trial
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
PD-L1 Inhibition With Avelumab for Metastatic Merkel Cell Carcinoma
Expert Review of Clinical Pharmacology
Medicine
Toxicology
Pharmaceutics
Pharmacology
Efficacy and Safety of First-Line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
JAMA Oncology
Cancer Research
Oncology
Minimal Impact on Patients’ Health Utilities Associated With Adverse Events in Metastatic Merkel Cell Carcinoma Patients on Treatment With Avelumab
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab
Frontiers in Oncology
Cancer Research
Oncology
Predictors of Progression-Free Survival and Overall Survival in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Single-Center Experience
World Journal of Oncology
Cancer Research
Oncology
Impact of Comorbidity on Overall Survival in Patients Surgically Treated for Renal Cell Carcinoma
Urology
Urology
Avelumab in the Treatment of Patients With Merkel Cell Carcinoma: Initial Results of Early Access Program in Russia
Malignant tumours
Case Report: Metastatic Esophageal Squamous Cell Carcinoma Successfully Treated With Immunotherapy: First Case Report in Thailand.
The Bangkok Medical Journal
